Showing results (31-40 of 154) with videos related to

Sort By:
Pageof 16
Expert Review of Anticancer Therapy|October 18, 2002
Potential of DMXAA combination therapy for solid tumorsBruce C Baguley, William R Wilson
Magnetic Resonance in Chemistry : MRC|August 11, 2006
Complete 1H, 13C and 15N NMR assignment of tirapazamine and related 1,2,4-benzotriazine N-oxidesMaruta Boyd, Michael P Hay, Peter D W Boyd
Molecules (Basel, Switzerland)|October 27, 2020
Subcellular Location of Tirapazamine Reduction Dramatically Affects Aerobic but Not Anoxic CytotoxicityChris P Guise, Maria R Abbattista, Robert F Anderson, et al.
Chemistry, an Asian Journal|August 23, 2024
Novel Prodrug Strategies for the Treatment of TuberculosisChristine G Kim, Jiney Jose, Michael P Hay, et al.
Journal of the American Chemical Society|March 27, 2009
One-electron reduction potential of the neutral guanyl radical in the GC base pair of duplex DNASujata S Shinde, Andrej Maroz, Michael P Hay, et al.
Advances in Experimental Medicine and Biology|June 22, 2016
Efficient Protocol for the Identification of Hypoxic Cell RadiosensitisersCho Rong Hong, Jingli Wang, Kevin O Hicks, et al.
The Biochemical Journal|March 14, 2013
FSL-61 is a 6-nitroquinolone fluorogenic probe for one-electron reductases in hypoxic cellsJiechuang Su, Christopher P Guise, William R Wilson
Nature Reviews. Clinical Oncology|July 30, 2021
Therapeutic targeting of the hypoxic tumour microenvironmentDean C Singleton, Andrew Macann, William R Wilson
The Journal of Pharmacology and Experimental Therapeutics|March 24, 2011
Glucuronidation of anticancer prodrug PR-104A: species differences, identification of human UDP-glucuronosyltransferases, and implications for therapyYongchuan Gu, Malcolm D Tingle, William R Wilson
Pageof 16